Distribución heterogénea de la prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre en Puebla, México

Objective. To determine the seroprevalence and associated factors, of antibodies against Trypanosoma cruzi (T. cruzi Ab) among blood donors living in rural and suburban areas and risk regions. Material and Methods. A cross-sectional study was conducted from January to December 2003, in 2489 blood donors of seven regions of Puebla, who were evaluated for mandatory viral and T. cruzi serological tests using validated procedures Results. The seroprevalence for T. cruzi Ab was 1.24% (31/2489), similar to hepatitis C (HVC) (1.5%) and higher than human immunodeficiency virus (HIV) (0.4%) and hepatitis B (HVB) (0.3%). The highest seroprevalences were observed in the regions of Tehuacan-Sierra Negra and Mixteca, up to 2.6%, while in Sierra nororiental and Angelopolis no positive blood donors were identified. A positive association was observed between seropositivity and being older than forty years and being born and raised in Tehuacan-Sierra Negra and Mixteca. Conclusions. T.cruzi seroprevalence distribution is heterogeneous, from 0% to 2.6%, with higher seroprevalences in the regions of Tehuacan-Sierra Negra and Mixteca.

[1]  María Lilia Cedillo Ramírez,et al.  Infección natural con Trypanosoma cruzi en triatominos (Hemiptera: reduviidae: triatominae), vectores de la enfermedad de Chagas en San Antonio Rayón, Jonotla, Puebla, México , 2004 .

[2]  P. Reyes,et al.  Factores bióticos y abióticos que determinan la seroprevalencia de anticuerpos contra Trypanosoma Cruzi en el municipio de Palmar de Bravo, Puebla, México , 2004 .

[3]  J. Guégan,et al.  High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico. , 2002, Memorias do Instituto Oswaldo Cruz.

[4]  C. Guzmán-Bracho,et al.  American trypanosomiasis (Chagas' disease) and blood banking in Mexico City: seroprevalence and its potential transfusional transmission risk. , 1999, Archives of medical research.

[5]  M. T. Cosme,et al.  Riesgo de transmisión de Trypanosoma cruzi por transfusión de sangre en México , 1998 .

[6]  J. L. Rosales-Encína,et al.  Humoral nitric oxide levels and antibody immune response of symptomatic and indeterminate Chagas' disease patients to commercial and autochthonous Trypanosoma cruzi antigen. , 1998, The American journal of tropical medicine and hygiene.

[7]  C. Ramos,et al.  Detection of antibodies against Trypanosoma cruzi in donors from a blood bank in Cuernavaca, Morelos, Mexico. , 1998, Archives of Medical Research.

[8]  P. Reyes,et al.  Diagnóstico serológico de la enfermedad de chagas : autosuficiencia y concordancia interlaboratorios , 1995 .

[9]  Felipe Lozano Kasten,et al.  Prevalencia de infeccion a Trypanosoma cruzi en donadores de sangre en el Estado de Jalisco, Mexico , 1993 .

[10]  Víctor M Monteón-Padilla,et al.  Detección de anticuerpos contra trypanosoma cruzi en donadores de sangre , 1993 .

[11]  G. Gutiérrez,et al.  Seroepidemiología de la enfermedad de Chagas en México , 1992 .

[12]  I. L. Sinhorini,et al.  The influence of lymphatic drainage in experimental Trypanosoma cruzi infection. , 1984, Acta tropica.

[13]  Goldsmith Rs,et al.  El potencial de la transmisión en la enfermedad de Chagas por transfusión sanguínea: hallazgos serológicos entre donadores en el estado de Oaxaca , 1978 .

[14]  D. M. Minter Epidemiology of Chagas' disease. , 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15]  M. Álvarez,et al.  Enfermedad de Chagas y la transfusión de sangre , 1972 .

[16]  J. Defreitas,et al.  [Epidemiology of Chagas' disease]. , 1961, Hospital.